ORCHPHARMA
Invest with MTF
Invest Now
Invest in Orchid Pharma with 2.22X leverage
Orchid Pharma live price: ₹519.45. It opened at ₹536 vs previous close ₹541; intraday high/low: ₹547/₹517. The 50 & 200 DMA stand at ₹658.05/₹773.86.
Orchid Pharma Performance
- Low
- ₹517
- High
- ₹547
- 52 Week Low
- ₹489
- 52 Week High
- ₹899
- Open Price₹536
- Previous Close₹541
- Volume67,117
- 50 DMA₹658.05
- 100 DMA₹705.95
- 200 DMA₹773.86
Investment Returns
- Over 1 Month -22.72%
- Over 3 Month -38.88%
- Over 6 Month -26.92%
- Over 1 Year -37.42%
Smart Investing Starts Here Start SIP with Orchid Pharma for Steady Growth!
Orchid Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 139.6
- PEG Ratio
- -1.7
- Market Cap Cr
- 2,635
- P/B Ratio
- 2.1
- Average True Range
- 27.95
- EPS
- 5.12
- Dividend Yield
- 0
- MACD Signal
- -40.24
- RSI
- 29.5
- MFI
- 23.34
Orchid Pharma Financials
Orchid Pharma Technicals
EMA & SMA
Current Price
₹519.45
-21.4
(-3.96%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹592.09
- 50 Day
- ₹658.05
- 100 Day
- ₹705.95
- 200 Day
- ₹773.86
Resistance and Support
532.4
- R3 596.70
- R2 572.45
- R1 556.65
- S1 516.60
- S2 492.35
- S3 476.55
Orchid Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-11 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-12 | Quarterly Results |
Orchid Pharma F&O
About Orchid Pharma
- NSE Symbol
- ORCHPHARMA
- BSE Symbol
- 524372
- Managing Director
- Mr. Manish Dhanuka
- ISIN
- INE191A01027
Similar Stocks to Orchid Pharma
Orchid Pharma FAQs
Orchid Pharma share price is ₹519 As on 13 March, 2026 | 12:38
The Market Cap of Orchid Pharma is ₹2634.6 Cr As on 13 March, 2026 | 12:38
The P/E ratio of Orchid Pharma is 139.6 As on 13 March, 2026 | 12:38
The PB ratio of Orchid Pharma is 2.1 As on 13 March, 2026 | 12:38
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.